Former Biogen CEO Michel Vounatsos Joins Quris-AI Board
Yossi Ben Amram Appointed President as Bio-AI Innovator Continues to Expand Roster of Influential Experts Guiding Its Global Growth Yossi...
Big Data
Biomedical Technology Veteran Mike Hess Joins IEEE Pulse as Editor-in-Chief
PISCATAWAY, N.J.--(BUSINESS WIRE)--IEEE, the world’s largest technical professional organization dedicated to advancing technology for humanity, and the IEEE Engineering in...
Blue Horizon Announces CSE Approval of Change of Business and Commencement Date of Trading
Toronto, Ontario--(Newsfile Corp. - December 27, 2023) - Blue Horizon Global Capital Corp. (CSE: SENS) (CSE: BHCC) (formerly Sensor Technologies...
Ainos, Nisshinbo Micro Devices and Inabata Initiate Phase 2 of VOC Co-development Powered by AI Nose, Accelerating the Digitalization of Smell
Mass Production Readiness Targeted for 2H 2024Propelling AI Nose Technology Towards Broader Industry Adoption and Advancing the Mission of Digitalizing...
BioXcel Therapeutics Hosting Virtual Neuroscience R&D Day Today
Company to review BXCL502 and other potential emerging pipeline candidates Dr. Jeffrey Cummings to discuss agitation relief in Alzheimer’s disease and...
At RSNA 2023, AGFA HealthCare Presents the Application of Generative AI in Radiology, as Well as New RUBEE(R) AI Specialty Packages
AGFA HealthCare will demonstrate the power of Enterprise Imaging innovations by showcasing new RUBEE® AI Packages and RUBEE® AI Integrations...
Pierre Fabre Laboratories Collaborates With Chowis Company to Analyze Skin, Hair, and Scalp With AI Diagnostic Solutions
SEOUL, SOUTH KOREA / ACCESSWIRE / November 24, 2023 / Chowis Company ("Chowis"), a specialist in skin, hair and scalp...
Healthcare’s Outsourcing Boom on a Trajectory to Double by 2027, Black Book 20th Annual Industry Study
Management representatives from 1,428 provider organizations are electing to deflect mounting solution delivery concerns to outsourcing vendors, according to 91%...
Tenth Patient With Depression Starts Dosing MB22001 in Take Home Microdosing Trials
VANCOUVER, BC / ACCESSWIRE / October 5, 2023 / MindBio Therapeutics Corp. (CSE:MBIO);(Frankfurt:WF6), (the "Company" or "MindBio"), is pleased to...
Merck KGaA, Darmstadt, Germany and Quris-AI Expand Collaboration
Companies Extend Collaboration After Successful Preclinical Study Assessed the Quris-AI BioAI Drug Safety PlatformBOSTON and TEL AVIV, Israel, Sept. 28,...
Neusoft Holds the Top Market Share of Medical Imaging Information System in China
SHENYANG, China, Sept. 19, 2023 /PRNewswire/ -- Recently, IDC released the report "China's Medical Imaging Information System Market Share in 2022",...
Digital Biomarker Market Size to Grow USD 22360 Million by 2029 at a CAGR of 82.5% | Valuates Reports
BANGALORE, India, Sept. 14, 2023 /PRNewswire/ -- Digital Biomarker Market is Segmented by Type (Passive Digital Biomarker, Active Digital Biomarker),...
CalmWave Appoints Dr. Richard Schaefer, Chief Health Informatics Officer of the U.S. Department of Veterans Affairs, to Board of Advisors
Renowned Leader in Healthcare Technology Including AI Joins Esteemed Clinicians and ICU Physicians on Advisory BoardSEATTLE--(BUSINESS WIRE)--CalmWave, the company leveraging...
MindBio Therapeutics Announces Major Genetic Discovery in Microdosing Research
Genetic Discovery: MindBio's genetic testing in clinical research yields novel discovery for targeted diagnosis and treatmentSignificant Intellectual Property & Know...
Superluminal Medicines Launches with $33 Million Seed Round to Fuel its Drug Discovery Engine and Pipeline of Small Molecule Therapeutics
Financing led by RA Capital Management with participation from Insight Partners, NVIDIA, and Gaingels Superluminal combines deep biology and chemistry...
Wisconsin’s Pioneering Pathway Seeks to Secure Tech Hub Designation in Personalized Medicine
Madison, Wisconsin--(Newsfile Corp. - August 18, 2023) - Building on Wisconsin's statewide position of strength in personalized medicine, biohealth technology,...
Mindbio Therapeutics First Batch of MB22001 has Been Manufactured and is Ready for Use in World First Phase 2 Take at Home Psychedelic Clinical Trials
MB22001 has been manufactured ready for use in Phase 2 clinical trialsWorld first take-home approvals for psychedelic microdosingVANCOUVER, BC /...
Parexel and Partex Announce Innovative Alliance Leveraging Artificial Intelligence and Big Data to Accelerate Drug Discovery and Development
Collaboration combines clinical research expertise with artificial intelligence capabilities to help drug developers better understand the probability of clinical success...
Ainos Partners with Nisshinbo Micro Devices and Inabata to Co-Develop VOC Sensing Platform For Broader Industry Adoption
The Collaboration Signals Era of New Innovation for AI Nose Technology for Broader Industry AdoptionWith Partnership, Ainos Makes Progress Towards...
DLH to Expand Digital Transformation Services at the National Heart, Lung, and Blood Institute
ATLANTA, Aug. 02, 2023 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of...